πŸ‡ΊπŸ‡Έ FDA
Patent

US 9115139

Pyrazinooxazepine derivatives

granted A61KA61K9/2018A61K9/2059

Quick answer

US patent 9115139 (Pyrazinooxazepine derivatives) held by Takeda Pharmaceutical Company Limited expires Mon Aug 20 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Aug 25 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 20 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K9/2018, A61K9/2059, A61K9/286, A61P